Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia.

TORONTO, Jan. 28, 2025 /CNW/ - PricewaterhouseCoopers Inc., solely in its capacity as receiver and manager of Victoria Gold Corp. ("VGC"), announced today that 42,132,139 common shares ("Shares") of ...

Though GNN has reported that several sickle cell disease patients have already been successfully treated with CRISPR gene editing technology, a new method of addressing this debilitating condition ...

When the FDA approved Casgevy as the first therapy using CRISPR gene-editing technology in 2023, sickle cell anemia patients and their caregivers were astonished, hopeful, and concerned. It had been ...

FRIDAY, Jan. 24, 2025 (HealthDay News) -- People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in school and the workplace.

The Food and Drug Administration approval in December 2023 of the first CRISPR therapeutic, Casgevy to treat sickle cell, came 11 years after the discovery of the revolutionary gene-editing technology ...

Victoria Gray of Bedford also is within striking range. She stands at 864 with at least 14 games remaining in her senior season. If she maintains her current average of 19 points per game ...

Department of Chemical and Biomolecular Engineering (BK21 Four), Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea ...

Sickle cell anaemia occurs when red blood cells change shape under low oxygen conditions, transforming into a sickle shape that can block blood flow. This blockage can result in pain in the ...

But for a brief moment on a recent December morning, Wedam, 19, who has sickle cell disease ... will use a gene-editing tool called CRISPR to modify a gene in the stem cells so they produce ...